Serum cytokine and vitamin levels in experimental diabetic rats

Journal of Animal and Veterinary Advances

Volumn 10, Issue 5, 2011, Pages 622-626

  Yazar, Mete ^a   Deger, Yeter ^a   Yur, Fatmagul ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Cytokine; Diabetes mellitus; Oxygen radicals; Rat; Turkey; Vitamin

Indexed keywords

EID: 79951498517     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2011.622.626     Document Type: Article

References (39)

1. Baena, R.M., C. Campoy, R. Bayes, E. Blanca, J.M. Fernandez and J.A. Molina-Font 2002. Vitamin A, retinol binding protein and lipids in type 1 diabetes mellitus. Eur. J. Clin. Nutr., 56: 44-50.
2. Basu, T.K., W.J. Tze and J. Leichter, 1989. Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am. J. Clin. Nutr., 50: 329-331.
3. Baumgartl, H.J., E. Standi, H. Schmidt-Gayk, H.J. Kolb, H.U. Janka and A.G. Ziegler, 1991. Changes of vitamin D3 serum concentrations at the onset of immune- mediated type 1 (insulin-dependent) diabetes mellitus. Diabetes Res., 16: 145-148.
4. Broedl, U.C. and B. Goke, 2006. Molecular diagnosis of diabetes mellitus. Internist, 47: 47-54.
5. Cavallo, M.G., P. Pozzilh, C. Bird, M. Wadhwa and A. Meager et al, 1991. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin. Exp. Immunol, 86: 256-259.
6. Cnop, M., N. Welsh, J.C. Jonas, A. Joins, S. Lenzen and D.L. Eizirik, 2005. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes, 2: 97-107.
7. Espe, K., A. Galler, J. Raila, W. Kiess and F.J. Schweigert, 2007. High-normal C-reactive protein levels do not affect the vitamin A transport complex in serum of children and adolescents with type 1 diabetes. Pediatr. Res., 62: 741-745.
8. Fidan, I., S. Yuksel, A. Kalkanci, T. Imir and S. Kustimur, 2005. Evaluation of the natural killer cytotoxicity and the levels of cytokines in rats with type I diabetes mellitus. Mem. Inst. Oswaldo Cruz, 100: 883-887.
9. Frazer, T.E., N.H. White, S. Hough, J. V. Santiago and B.R. McGee et al., 1981. Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J. Clin. Endocrinol. Metab., 53: 1154-1159.
10. Grunnet, L.G., R. Aikin, M.F. Tonnesen, S. Paraskevas and L. Blaabjerg et al., 2009. Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes, 58: 1807-1815.
11. Gysemans, C, H. Callewaert, L. Overbergh and C. Mathieu, 2008. Cytokine signalling in the β-cell: A dual role for IFN gamma. Biochem. Soc. Trans., 36: 328-333.
12. Haller, M.J. and D.A. Shatz, 2008. Cytokines and type 1 diabetes complications: Casual or causal association. Pediatr. Diabetes, 9: 1-2.
13. Hozumi, M., T. Murata, T. Morinobu, M. Manago and T. Kuno et al., 1998. Plasma beta-carotene, retinol and alpha-tocopherol levels in relation to glycemic control of children with insulin-dependent diabetes mellitus. J. Nutr. Sci. Vitaminol., 44: 1-9.
14. Hypponen, E., E. Laara, A. Reunanen, M.R. Jarvelin and S.M. Virtanen, 2001. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet, 358: 1500-1503.
15. Imura, H., Y. Seino and H. Ishida, 1985. Osteopenia and circulating levels of vitamin D metabolites in diabetes mellitus. J. Nutr. Sci. Vitaminol. (Tokyo), 31: S27-S32.
16. Kang,M.K., Y.E. Yoon, J.Y. Yang, K.B. Kwon, J.W. Park and E.C. Jhee, 2004. Protective effect of retinoic acid on interleukin-1 beta-induced cytotoxicity of pancreatic beta-cells. Mech. Ageing. Dev., 125: 483-490.
17. Kaye, W.A., M.N. Adri, J.S. Soeldner, S.L. Rabinowe and A. Kaldany et al., 1986. Acquired defect in interleukin-2 production in patients with type 1 diabetes mellitus. N. Engl. J. Med., 315: 920-924.
18. King, G.L. and M.R. Loeken, 2004. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem. Cell Biol., 122: 333-338.
19. Lencioni, C, R. Lupi and S. Del Prato, 2008. Beta-cell failure in type 2 diabetes mellitus. Curr. Diab. Rep., 8: 179-184.
20. Lernmark, A., 1999. Type 1 diabetes. Clin. Chem., 45: 1331-1338.
21. Mathieu, C, M. Waer, J. Laureys, O. Rutgeerts and R. Bouillon, 1994. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia, 37: 552-558.
22. Miller, K.W. and C.S. Yang, 1985. An isocratic high-performance liquid chromatography method for the simultaneous analysis of plasma retinol, alpha-tocopherol and various carotenoids. Anal. Biochem., 145: 21-26.
23. Munoz-Torres, M., J.D. de Madrid, F. Escobar-Jimenez and N.O. Centeno, 1990. Serum 1,25-dihydroxyvitamin D in insulin-dependent diabetes mellitus. Med. Clin. (Barc)., 95: 207-209.
24. Pennline, K.J., E. Roque-Gaffiney and M. Monahan, 1994. Recombinant IL-10 prevents the onset of diabetes in the non-obese diabetic mouse. Clin. Immunol. Immunopathol., 71: 169-175.
25. Rabinovitch, A. and W.L. Suarez-Pinzon, 2007. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Cell Biochem. Biophys., 48: 159-163.
26. Rabinovitch, A., 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of ID DM. Therapeutic intervention by immunostimulation. Diabetes, 43: 613-621.
27. Reynolds, S.L. and H.J. Judd, 1984. Rapid procedure for the determination of vitamins A and D in fortified skimmed milk powder using high-performance liquid chromatography. Analyst 109: 489-492.
28. Schloot, N.C., P. Hanifi-Moghaddam, C. Goebel, S.V. Shatavi, S. Flohe, H. Kolb and H. Rothe, 2002. Serum IFN-ã and IL-10 levels are associated with disease progression in non-obese diabetic mice. Diabet. Metab. Res. Rev., 18: 64-70.
29. Stene, L.C. and G. Joner, 2003. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: A large, population-based, case-control study. Am. J. Clin. Nutr., 78: 1128-1134.
30. Tajiri, Y. and V.E. Grill, 1999. Interactions between vitamin E and glucose on B-cell functions in the rat: An in vivo and in vitro study. Pancreas, 18: 274-281.
31. Takiishi, T., C. Gysemans, R. Bouillon and C. Mathieu, 2010. Vitamin D and diabetes. Endocrinol. Metab. Clin. North Am., 39: 419-446.
32. Tilg, H. and A.R. Moschen, 2008. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med., 14: 222-231.
33. Tisch, R. and H. McDevitt, 1996. Insulin-dependent diabetes mellitus. Cell, 85: 291-297.
34. Vessby, J., S. Basu, R. Mohsen, C. Berne and B. Vessby. 2002. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J. Intern. Med., 251: 69-76.
35. Walsh, G., 2004. Biopharmaceuticals, Biochemistry and Biotechnology. 2nd Edn., John Wiley and Sons Ltd.. England, pp: 189-253.
36. Wedrychowicz, A., H. Dziatkowiak, K. Sztefko and A. Wedrychowicz, 2004. Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes. 112: 435-439.
37. Zaspel, B.J. and S. Csallany, 1983. Determination of alpha-tocopherol in tissues and plasma by high-performance liquid chromatography. Anal. Biochem., 130: 146-150.
38. Zier, K.S., M.M.Leo, R.S. Spielman and L. Baker, 1984. Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus. Diabetes, 33: 552-555.
39. Zunino, S.J., D.H. Storms and C.B. Stephensen, 2007. Diets rich in polyphenols and vitamin A inhibit the development of type 1 autoimmune diabetes in nonobese diabetic mice. J. Nutr., 137: 1216-1221.